Skip to main content

Table 3 Plasma cholesterol and triacylglycerol in hamsters treated with G. lucidum and lovastatin (mmol/L)

From: Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs

Group

TC

TC

TAG

TAG

VLDL

LDL

HDL

LDL/HDL

 

D1

D18

D1

D18

D18

D18

D18

D18

Control

3.57

3.48

1.10

1.08

0.22

0.51

2.75

0.19

Lovastatin

3.39

3.16a

1.07

0.98

0.18a*

0.48

2.50a

0.19

Gl (2.5%)

3.46

3.40

0.64a

0.90a

0.18

0.53

2.69

0.20

Gl (5%)

3.34

3.14a*

0.89a*

0.92a

0.20

0.49

2.44a*

0.20

  1. TC, total cholesterol; TAG, triacylglycerol; VLDL, LDL, HDL, very low-, low-, and high-density lipoproteins; D, day; LOVA, 20 mg/kg diet. Values represent mean of 6 animals. aSignificantly different from the control (P < 0.05 or *P < 0.10), students, unpaired, 1-tailed,t-test, equal variances.